B Cells--Tumors clinical trials at University of California Health

1 research study open to eligible people

Study of Experimental STRO-001 in Patients With Advanced B-Cell Malignancies (Cancer)
open to eligible people ages 18 years and up
First-in-human Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-001 given intravenously every 3 weeks.
at UC Davis UCSF

Our lead scientists for B Cells--Tumors medical studies include Joseph Tuscano, MD Nina Shah, MD.

Last updated: October 2020